Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. H.W. (Hans) Nijman


A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands

Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

Prognostic benefit of TILs independent of clinicopathological and molecular factors

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide study

Tumour-infiltrating lymphocytes: from prognosis to treatment selection

Automated causal inference in application to randomized controlled clinical trials

Development of 89 Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration

Read more


UMCG ontvangt subsidie voor onderzoek naar immuuntherapie bij baarmoederkanker

„Werk aan de winkel met kankerpreventie”

Subsidie voor minder belastende behandeling schaamlipkanker

Onderzoek naar minder belastende behandeling schaamlipkanker

Subsidie voor minder belastende behandeling schaamlipkanker

Immunicum Immunicum AB (publ) Interim Report April - June 2021 (GlobeNewswire)

A Fast Track for Cancer Vaccines

Interview bij ZonMW

Immunoncologie artikel therapeutisch HPV vaccin voor cervixcarcinoom

Read more